Read + Share
Amedeo Smart
Independent Medical Education
Shah A, O'Horo JC. In patients with COVID-19 receiving IMV or ECMO, adding baricitinib to usual care reduced all-cause mortality. Ann Intern Med 2022 Jun 7. doi: 10.7326/J22-0033.PMID: 35667076
Email
LinkedIn
Facebook
Twitter
Privacy Policy